$3.73
-0.035-0.93%
Last update: Oct 1, 12:03 PM
$3.77
N/A
Relmada Therapeutics Inc (RLMD) Stock Price, Quote, News & History
RLMDNASDAQ
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Relmada Therapeutics (NASDAQ:RLMD) through any online brokerage.
Other companies in Relmada Therapeutics’s space includes: Eli Lilly and Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co Inc (NYSE:MRK), Novartis AG (NYSE:NVS) and AstraZeneca PLC (NYSE:AZN).
Relmada Therapeutics has a consensus price target of $10.00.
The stock price for Relmada Therapeutics (NASDAQ: RLMD) is $3.735 last updated October 1, 2026 at 12:03 PM EDT.
There are no upcoming dividends for Relmada Therapeutics.
Relmada Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for Relmada Therapeutics.
Relmada Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Relmada Therapeutics Inc is a clinical-stage, publicly traded biotechnology company focused on the development of NDV-01 and sepranolone. NDV-01 is a novel, controlled-release intravesical formulation of gemcitabine and docetaxel. NDV-01 is currently...
